Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
143.90
-1.81 (-1.24%)
Streaming Delayed Price
Updated: 1:26 PM EDT, Sep 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,959,143
Open
145.39
Bid (Size)
143.89 (200)
Ask (Size)
143.91 (200)
Prev. Close
145.71
Today's Range
143.67 - 145.50
52wk Range
121.57 - 170.46
Shares Outstanding
N/A
Dividend Yield
3.32%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
September 29, 2026
From
Pomerantz LLP
Via
GlobeNewswire
At the Longevity Investors Conference in Gstaad, Investors Test Which Longevity Claims Hold Up
September 29, 2026
DATELINE]As longevity research moves from animal models into human trials, investors are asking a sharper question: what is science, and...
Via
Newsfile
Performance
YTD
+3.9%
+3.9%
1 Month
-5.4%
-5.4%
3 Month
-8.2%
-8.2%
6 Month
-5.8%
-5.8%
1 Year
+16.0%
+16.0%
More News
Read More
Novartis (NYSE:NVS) Offers Dividend Investors a Quality Income Profile
↗
September 26, 2026
Via
Chartmill
Leaders Face Stark Warning from Silicon Valley Veteran – The Old Way of Working is Dead
September 25, 2026
Via
Get News
Topics
Artificial Intelligence
Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?
↗
September 17, 2026
Via
The Motley Fool
Worried About a Market Crash? This Dividend Stock Outperformed as the S&P 500 Sank in Both 2008 and 2022
↗
September 16, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Stocks
Novartis Suffers Another Setback After Two High-Profile Surprises Hammered Shares
↗
September 16, 2026
Via
Investor's Business Daily
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?
↗
September 15, 2026
Via
The Motley Fool
Topics
ETFs
Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.
↗
September 14, 2026
Via
The Motley Fool
Amgen Drops 10% on a Trial It Didn't Even Run
↗
September 11, 2026
Via
MarketBeat
Top Investor Urges Novartis for Stronger Acquisition Oversight After M&A and Trial Setbacks
↗
September 11, 2026
Via
Benzinga
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
September 10, 2026
Via
Investor Brand Network
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
September 10, 2026
Via
Investor Brand Network
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance
September 10, 2026
Via
Investor Brand Network
2025 R&D Spending And Intensity Benchmarks
September 09, 2026
Via
PRLog
Topics
Supply Chain
Stock Market Today, Sept. 8: Stocks Slide Amid Surging Oil Prices, Persistent Geopolotical Tenisons
↗
September 08, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Stocks
World Trade
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
September 10, 2026
From
BioMedWire
Via
GlobeNewswire
A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower
↗
September 08, 2026
Via
Benzinga
Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling
↗
September 08, 2026
Via
Benzinga
How Novartis And Ionis' High-Profile Failure Reverberated Through Biopharma
↗
September 08, 2026
Via
Investor's Business Daily
Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
↗
September 08, 2026
Via
Benzinga
Novartis Stock Drops as Trial Failures Ripple Across Biotech Partners
↗
September 08, 2026
Via
Benzinga
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday
↗
September 08, 2026
Via
Benzinga
Novartis, Ionis Tumble On Surprise Flop For Heart Drug
↗
September 04, 2026
Via
Investor's Business Daily
A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths
↗
September 04, 2026
Via
Benzinga
Topics
Death
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 143.90
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 09/30/26 01:26 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today